Marlene Debel - Feb 28, 2023 Form 4 Insider Report for METLIFE INC (MET)

Role
EVP & Chief Risk Officer
Signature
/s/ Stephen W. Gauster, Authorized Signer
Stock symbol
MET
Transactions as of
Feb 28, 2023
Transactions value $
-$1,212,213
Form type
4
Date filed
3/2/2023, 05:55 PM
Previous filing
Feb 27, 2023
Next filing
Aug 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award +5.54K +10.02% 60.8K Feb 28, 2023 Direct F1
transaction MET Common Stock Award +32.2K +52.91% 93K Feb 28, 2023 Direct F2
transaction MET Common Stock Tax liability -$1.03M -14.4K -15.44% $71.73 78.7K Feb 28, 2023 Direct F3
transaction MET Common Stock Tax liability -$182K -2.55K -3.24% $71.27 76.1K Mar 1, 2023 Direct F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MET Employee Stock Options (right to buy) Award $0 +16.6K $0.00 16.6K Feb 28, 2023 Common Stock 16.6K $71.73 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
F2 Shares acquired from the determination of the performance factor for and payout of 2020-2022 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
F3 Shares withheld to satisfy the reporting person's tax withholding obligation due on the performance share payout.
F4 Withheld for taxes on shares issued for restricted stock units.
F5 The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.